Results 161 to 170 of about 6,363 (176)

Review of siltuximab in the treatment of multicentric Castleman’s disease

Therapeutic Advances in Hematology, 2016
Shayna Sarosiek, Nikhil C Munshi
exaly  

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease

Annals of Oncology, 2009
T Powles, J Stebbing, Eleftheria Hatzimichael   +2 more
exaly  

Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics

Oncologist, 2011
Razelle Kurzrock
exaly  

Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan

Modern Rheumatology, 2020
Takeshi Johkoh, Shin-Ichi Nakatsuka, Johkoh Takeshi   +2 more
exaly  

Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease

Modern Pathology, 2013
Kung-Chao Chang, Liang-Yi Hung, Wan-Ting Huang   +2 more
exaly  

Castleman disease of the neck: CT and MR imaging findings

European Journal of Radiology, 2014
Qing-Yu Liu, Yun Cao, Wei-Dong Zhang
exaly  

Treatment of Idiopathic Castleman Disease

Hematology/Oncology Clinics of North America, 2018
, Katie Stone
exaly  

Multicentric Castleman disease with TAFRO syndrome and Sjögren's

Clinical Case Reports (discontinued), 2019
Zi Ying Li
exaly  

Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman’s disease of the nasopharynx: tracing its evolution by sequential biopsies

Histopathology, 2001
J K C Chan, W Y Au, Wai Kuen Ho
exaly  

Castleman's tumours and production of autoantibody in paraneoplastic pemphigus

Lancet, The, 2004
Liangchun Wang, Dingfang Bu, Xuejun Zhu   +2 more
exaly